We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

86 hedge funds and large institutions have $148M invested in BioSpecifics Technologies Corp. in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 42 increasing their positions, 21 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 21

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

4% more funds holding

Funds holding: 8386 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less capital invested

Capital invested by funds: $152M → $148M (-$4.9M)

Holders
86
Holders Change
+3
Holders Change %
+3.61%
% of All Funds
2.4%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
42
Reduced
21
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SO
51
STRS Ohio
Ohio
$391K
DC
52
Deere & Company
Illinois
$388K +$480K +8,900 New
BG
53
BlackRock Group
United Kingdom
$385K -$134K -2,490 -22%
New York State Common Retirement Fund
54
New York State Common Retirement Fund
New York
$385K +$37.8K +700 +9%
TA
55
Teachers Advisors
New York
$305K
CAM
56
ClariVest Asset Management
California
$274K
HIM
57
Hillsdale Investment Management
Ontario, Canada
$242K -$16.2K -300 -5%
UBS Group
58
UBS Group
Switzerland
$234K +$156K +2,882 +115%
DCM
59
Dupont Capital Management
Delaware
$223K +$276K +5,113 New
DIA
60
Denver Investment Advisors
Colorado
$211K -$9.01K -167 -3%
SEI Investments
61
SEI Investments
Pennsylvania
$184K +$226K +4,181 +8,198%
MLICM
62
Metropolitan Life Insurance Company (MetLife)
New York
$165K
NFA
63
Nationwide Fund Advisors
Ohio
$138K
AIG
64
American International Group
New York
$126K +$162 +3 +0.1%
Bank of Montreal
65
Bank of Montreal
Ontario, Canada
$119K -$38.5K -714 -21%
US Bancorp
66
US Bancorp
Minnesota
$109K -$2.91K -54 -2%
LTFS
67
Ladenburg Thalmann Financial Services
Florida
$77K +$95.5K +1,770 +88,500%
Deutsche Bank
68
Deutsche Bank
Germany
$58K -$395K -7,325 -84%
Envestnet Asset Management
69
Envestnet Asset Management
Illinois
$50K +$61.8K +1,145 New
BNP Paribas Financial Markets
70
BNP Paribas Financial Markets
France
$42.5K +$30.5K +566 +138%
FQ
71
First Quadrant
California
$30K +$37.8K +700 New
TRCT
72
Tower Research Capital (TRC)
New York
$22K -$9.28K -172 -25%
BJ
73
BlackRock Japan
Japan
$18K -$1.4K -26 -6%
SGAM
74
Smith Group Asset Management
Texas
$18K
MA
75
MUFG Americas
New York
$15K -$27.5K -510 -59%

BSTC Hedge Fund Activity: Q3 2015 in Review

86 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2015, worth a combined $148M — down 3.2% from $152M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new BSTC positions and 8 closed out — a net gain of 3 holders — while 42 added to existing stakes and 21 trimmed.

The largest buyer was Allianz Asset Management, adding an estimated $5.28M. The largest seller was Franklin Resources, exiting entirely with an estimated $7.42M sold.

  • 86 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2015, up from 83 in Q2 2015.
  • Funds reported $148M of BioSpecifics Technologies Corp. stock for Q3 2015, down 3.2% quarter-over-quarter.
  • 11 funds opened new BioSpecifics Technologies Corp. positions in Q3 2015 and 8 closed out, a net change of +3 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q3 2015 was Allianz Asset Management, an estimated $5.28M added.
  • The largest BioSpecifics Technologies Corp. seller in Q3 2015 was Franklin Resources, an estimated $7.42M sold.

Based on aggregated 13F filings for Q3 2015.